NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/15/2020
Back to search
Official data from USPTO
COREALIS PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
COREALIS PHARMA
ST13
US500000077902871Class
40, 42
Filing
77902871
Registration
3964152
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
08/15/2020
Trademark type
Word
Nice classes
40, 42
Filing date
12/30/2009
Registration date
05/24/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/15/2020
Last transaction
08/15/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Foreign priority
First use anywhere
01/01/2006
First use in commerce
01/01/2006
Drawing code
4
Owner type
03
Owner location
Laval, Quebec, CA
Examiner
HAMMEL, LAURA A
Law office
L70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Corealis Pharma Inc.
Corealis Pharma Inc.
Representatives
Jess M. Collen Collen IP Intellectual Property Law, P.C.
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom manufacture of pharmaceutical solid oral drug products sold in capsuletabletgranule form
Class 42
Research and development in the fields of biotechnology and pharmaceuticals; development of chemical production methods
Publications
History of USPTO decisions and trademark events.
35 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/15/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/15/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/13/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
06/22/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/24/2020
NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
05/20/2017
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
05/20/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/18/2017
E15R
TEAS SECTION 15 RECEIVED
02/16/2017
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
06/12/2016
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
06/11/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/11/2016
ES8R
TEAS SECTION 8 RECEIVED
05/31/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/31/2016
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/14/2011
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/14/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
05/24/2011
PUBO
PUBLISHED FOR OPPOSITION
03/08/2011
NPUB
NOTICE OF PUBLICATION
02/16/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/02/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/28/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/26/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/25/2011
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/25/2011
CNSL
LETTER OF SUSPENSION MAILED
10/21/2010
CNSL
SUSPENSION LETTER WRITTEN
10/20/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/29/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/29/2010
ALIE
ASSIGNED TO LIE
09/29/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/21/2010
CNRT
NON-FINAL ACTION MAILED
03/29/2010
CNRT
NON-FINAL ACTION WRITTEN
03/26/2010
DOCK
ASSIGNED TO EXAMINER
03/25/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/05/2010
Continuous trademark protection
Get notified about every new filing that threatens COREALIS PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.